What Minnesota Medicaid actually covers for Wegovy, Zepbound, Ozempic and Mounjaro. Most state Medicaid programs still exclude weight-loss-indication GLP-1, but the diabetes path is covered nearly everywhere with prior authorization (your doctor asks the plan to approve it first). Here is the current 2026 reality for Minnesota.
Coverage summary
| Indication | Coverage |
|---|---|
| Wegovy (weight loss) | Limited |
| Zepbound (weight loss) | Limited |
| Ozempic / Mounjaro (type 2 diabetes) | Yes |
| Compounded semaglutide / tirzepatide | No |
Prior-authorization criteria
These rules come from the state preferred drug list (PDL), the list of drugs Minnesota Medicaid has agreed to pay for.
| Criterion | Value |
|---|---|
| PA burden | High |
| BMI threshold (weight-loss path) | BMI 30+ on its own, or BMI 27+ with a qualifying weight-related condition |
| Comorbidity required | Only for the BMI 27 to 30 range |
| Last PDL update reviewed | 2026-07-01 |
What this means in practice
Minnesota Medicaid covers Wegovy and Saxenda for weight loss at BMI 30 or higher. Zepbound is covered too, but it is nonpreferred, so the plan will want you to try Wegovy or Saxenda first. Either way your doctor has to ask the plan to approve it first. That is prior authorization. Same goes for the diabetes drugs.
Managed-care organizations in Minnesota (8 contracted)
Minnesota Medicaid contracts with the following managed-care organizations (MCOs), the private health plans the state pays to run day-to-day Medicaid coverage. MCO formularies must meet or exceed the state PDL but can layer in additional criteria. Verify your assigned MCO's most recent PA policy before submitting.
- Blue Plus
- HealthPartners
- Hennepin Health
- Medica
- UCare
- UnitedHealthcare Community Plan
Cash-pay alternatives if Medicaid does not cover you
Minnesota drops its bar to a BMI of 27 when your chart documents a weight-related condition, such as high blood pressure, high cholesterol or type 2 diabetes. Ask your prescriber to put that diagnosis in the prior-authorization file.
If you end up paying cash, the GLP-1 cost guide breaks down what every legitimate path actually costs at maintenance dose, from the $149-a-month compounded floor to branded manufacturer-direct pricing. For ranked cash-pay options, see programs ranked by price and programs under $150 a month. Manufacturer savings cards and patient-assistance programs are not routes here: federal law bars the cards for anyone on Medicaid, and the free-drug programs require being uninsured.
Two routes sit outside Medicaid entirely. If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.
For the full cash-pay picture specific to Minnesota, including which programs serve Minnesota residents and the Minnesota Medicaid cost comparison, see the cheapest GLP-1 in Minnesota guide.
Take it to your prescriber: PA letter library
If you qualify under one of the covered indications above, the prior-authorization route is the cheapest path. We maintain a PA letter library with templates for Aetna, Cigna, UnitedHealthcare, Anthem BCBS, Kaiser, Humana, Tricare, FEHB and Medicare Advantage, cross-indexed against six qualifying clinical pictures. Each template cites the plan's policy document, the qualifying ICD-10 codes and the registration-trial evidence.
If you have type 2 diabetes plus chronic kidney disease and established cardiovascular disease, the triple-indication evidence stack (FLOW + SELECT + SUSTAIN-6) is the strongest PA path in any state.
If your PA is denied, the appeal letter library has denial-specific templates. For the commercial and Medicare coverage paths, see the GLP-1 insurance guide.
Minnesota Medicaid GLP-1 FAQ
Does Minnesota Medicaid cover Wegovy for weight loss?
Does Minnesota Medicaid cover Zepbound for weight loss?
Does Minnesota Medicaid cover Ozempic or Mounjaro for diabetes?
What if Minnesota Medicaid does not cover my GLP-1?
Other state Medicaid pages
See the full 51-state coverage table for the side-by-side view across every US state.
How we built this page
Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.
Last updated: 2026-07-20. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Minnesota Medicaid, email hello@glpchart.com with the details and we will check it.
